Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

How is HKU5-CoV-2 similar to SARS-CoV-2? The discovery of HKU5-CoV-2 is concerning ... 10 point-explainer The research team, comprising experts from the Guangzhou Laboratory, Guangzhou Academy of ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

Today in BMC Medicine, researchers in Catalonia, Spain, estimate that 23% of adult COVID-19 survivors develop long COVID, ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...

Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind ...

Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...

Lower efficiency than Covid-19: While it can infect human cells, scientists have said its ability to do so is significantly weaker than SARS-CoV-2. The research team, led by Shi Zhengli ...

Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 ...

Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.